PolyTherics provides a range of technologies and services to develop biomedical polymers for therapeutic applications.
PolyTherics has focused on technology development in the area of biomedical polymers for therapeutic applications. The most advanced of its techniques, site-specific PEGylation or TheraPEG, is being exploited in partnership with companies developing biopharmaceuticals. PolyTherics is also committed to developing its own pipeline of optimised clinical candidates.
Announced Date | Round | Money Raised | Number of Investors | Lead Investors | Post Valuation | |
---|---|---|---|---|---|---|
Jul 26, 2013 | Series Unknown | £13.50M | 2 | — | — | Detail |
Sep 7, 2011 | Series Unknown | £2.15M | 1 | — | — | Detail |
Investor Name | Lead Investor | Funding Round |
---|---|---|
Invesco | — | Series Unknown |
Mercia Fund Managers | — | Series Unknown |
Venture Capital Trusts (VCTs) | — | Series Unknown |